| 1 |
34427852 | Glycyrrhizic Acid Alleviates Lipopolysaccharide (LPS)-Induced Acute Lung Injury by Regulating Angiotensin-Converting Enzyme-2 (ACE2) and Caveolin-1 Signaling Pathway. | 2022 Feb |
7 |
| 2 |
35279013 | Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations. | 2022 May |
1 |
| 3 |
32902005 | Glycyrrhizin: An old weapon against a novel coronavirus. | 2021 Feb |
1 |
| 4 |
34169390 | Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2. | 2021 Jun 24 |
1 |
| 5 |
34183961 | In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2. | 2021 May |
2 |
| 6 |
34507112 | Potential of herbal products in prevention and treatment of COVID-19. Literature review. | 2021 Nov |
1 |
| 7 |
34684671 | Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment. | 2021 Oct 9 |
3 |
| 8 |
34899289 | Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19. | 2021 |
1 |
| 9 |
32574273 | Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection? | 2020 |
1 |